SHPH$5.151.53%-0.08
Shuttle Pharmaceuticals Holdings Inc (SHPH)
Date: 2026-10-30 16:00O: 5.35H: 5.42L: 4.80C: 5.15Vol: 20.48k
Shuttle Pharmaceuticals Holdings Inc stock is traded at $5.15, with a volume of 20,479. It is down -1.53% in the last 24 hours and up +27.48% over the past month. Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Previous Close:
$5.23
Open:
$5.35
24h Volume:
20,479
Relative Volume:
0.69
Market Cap:
$24.54M
Revenue:
-
Net Income/Loss:
-$10.82M
P/E Ratio:
-
EPS:
-$6.06
Net Cash Flow:
-$9.42M
1W Performance:
+5.97%
1M Performance:
+27.48%
6M Performance:
-50.00%
1Y Performance:
-83.11%
1-Day Range:
$4.80$5.42
1-Week Range:
$4.80$5.60
52-Week Range:
$2.58$44.40
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings IncSector
HealthcarePhone
(240) 403-4212Address
401 PROFESSIONAL DRIVE, GAITHERSBURG, USACompare SHPH vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH Shuttle Pharmaceuticals Holdings Inc | $5.15 | $24.54M | $0 | -$10.82M | -$9.42M | -$6.06 |
 TAK Takeda Pharmaceutical Co Adr | $20.91 | $66.81B | $29.91B | $1.30B | $3.49B | $0.4056 |
 TEVA Teva Pharmaceutical Industries Ltd Adr | $42.09 | $49.09B | $17.53B | $1.58B | $444.18M | $1.35 |
 HLN Haleon Plc Adr | $8.66 | $38.08B | $14.54B | $2.22B | $2.58B | $0.4871 |
 ZTS Zoetis Inc | $79.72 | $32.94B | $9.51B | $2.64B | $2.14B | $6.04 |
 UTHR United Therapeutics Corp | $598.72 | $25.68B | $3.17B | $1.29B | $1.01B | $27.09 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
Net Income
Cash Flow
EPS
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Insider Trading
- HRT FINANCIAL LPJul 13 '2610% Owner
- Transaction
- Sale
- Cost
- $4.67
- #Shares
- 1,033
- Value ($)
- 4,824
- #Shares Total
- 60,238
- HRT FINANCIAL LPJul 10 '2610% Owner
- Transaction
- Buy
- Cost
- $3.11
- #Shares
- 731
- Value ($)
- 2,273
- #Shares Total
- 61,271
- HRT FINANCIAL LPJul 09 '2610% Owner
- Transaction
- Buy
- Cost
- $3.38
- #Shares
- 8,266
- Value ($)
- 27,939
- #Shares Total
- 60,540
- HRT FINANCIAL LPJul 08 '2610% Owner
- Transaction
- Sale
- Cost
- $3.52
- #Shares
- 18,531
- Value ($)
- 65,229
- #Shares Total
- 52,274
- HRT FINANCIAL LPJul 07 '2610% Owner
- Transaction
- Sale
- Cost
- $3.33
- #Shares
- 10,580
- Value ($)
- 35,231
- #Shares Total
- 70,805
- HRT FINANCIAL LPJul 06 '2610% Owner
- Transaction
- Sale
- Cost
- $3.51
- #Shares
- 9,022
- Value ($)
- 31,667
- #Shares Total
- 81,385
- HRT FINANCIAL LPJul 02 '2610% Owner
- Transaction
- Buy
- Cost
- $3.54
- #Shares
- 7,851
- Value ($)
- 27,793
- #Shares Total
- 90,407
- HRT FINANCIAL LPJul 01 '2610% Owner
- Transaction
- Buy
- Cost
- $3.30
- #Shares
- 3,959
- Value ($)
- 13,065
- #Shares Total
- 82,556
- HRT FINANCIAL LPJun 30 '2610% Owner
- Transaction
- Buy
- Cost
- $3.23
- #Shares
- 6,755
- Value ($)
- 21,819
- #Shares Total
- 78,597
- HRT FINANCIAL LPJun 29 '2610% Owner
- Transaction
- Buy
- Cost
- $3.44
- #Shares
- 25,836
- Value ($)
- 88,876
- #Shares Total
- 71,842
